We demonstrated decreased ER stress in BPD rat lungs by treating rat pups with the reversible MPO inhibitor N-acetyl-lysyltyrosylcysteine amide (KYC) with improved alveolar formation [21]. This evidence concerns the gene MPO and bronchopulmonary dysplasia.